Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86663 refers to a laboratory test that measures antibodies against the early antigen (EA) of the Epstein-Barr virus (EBV). This virus is known to cause infectious mononucleosis, a common viral infection primarily affecting children and young adults. The symptoms of this disease typically include fever, fatigue, sore throat, swollen lymph nodes, and in some cases, an enlarged spleen. EBV is transmitted through saliva, particularly during active infection, and it can persist in the body’s lymphocytes for life, occasionally reactivating without causing any symptoms. In addition to infectious mononucleosis, EBV is associated with certain serious conditions, including X-linked lymphoproliferative syndrome in males and various types of cancers such as Burkitt lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma. The early antigen (EA) IgG antibody test, represented by CPT® Code 86663, is specifically utilized to assist in diagnosing either an acute EBV infection or a reactivation of the virus. However, it is important to note that this test should not be used in isolation to diagnose the disease. Other related tests, such as the EBV nuclear antigen (EBNA) IgG antibody test (CPT® Code 86664) and the EBV viral capsid antigen (VCA) test for IgG and IgM antibodies (CPT® Code 86665), are also available and can provide additional information regarding past exposure to EBV and the diagnosis of primary EBV infectious mononucleosis when used in conjunction with other diagnostic tests. It is crucial to understand that the EBV VCA test for IgA antibodies is not suitable for diagnosing infectious mononucleosis but may be useful in detecting and assessing the prognosis of nasopharyngeal carcinoma. The test for CPT® Code 86663 requires a blood sample, which is obtained through a separately reportable venipuncture, and the serum is analyzed using a semi-quantitative chemiluminescent immunoassay method.
© Copyright 2026 Coding Ahead. All rights reserved.
The antibody test for Epstein-Barr virus (EBV), represented by CPT® Code 86663, is indicated for the following conditions:
The procedure for conducting the EBV early antigen (EA) IgG antibody test involves several key steps:
After the procedure, patients may experience minimal discomfort at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test, but patients should be advised to report any unusual symptoms or prolonged discomfort. The results of the test will be communicated to the healthcare provider, who will discuss the implications of the findings and any necessary follow-up actions based on the patient's clinical situation.
| Short Descr | EPSTEIN-BARR ANTIBODY | Medium Descr | ANTIBODY EPSTEIN-BARR EB VIRUS EARLY ANTIGEN EA | Long Descr | Antibody; Epstein-Barr (EB) virus, early antigen (EA) | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 77 | Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GA | Waiver of liability statement issued as required by payer policy, individual case | GW | Service not related to the hospice patient's terminal condition | GZ | Item or service expected to be denied as not reasonable and necessary |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.